Table of Contents
Table of Contents
Preface
Paclitaxel: Chemotherapy and Neurotoxicity-The Two Sides of the Coin;pp. 1-38
(Alessia Chiorazzi, Elisa Ballarini, Annalisa Canta, Valentina Alda Carozzi, Cecilia Ceresa, Daniele Maggioni, Gabriella Nicolini, Roberta Rigolio, Virginia Rodriguez-Menendez, Barbara Sala and Guido Cavaletti, Department of Neuroscience and Biomedical Technologies, University of Milan Bicocca, Monza, Italy)
Proteomics in the Discovery of Biomarkers of Chemoresistance: The Current Status of Paclitaxel Resistance in Human Epithelial Ovarian Cancer;pp. 39-69
(M. Di Michele, L. Cicchillitti, A. Della Corte, S. Marcone, M. D’Imperio, C. Ferlini, G. Scambia, M.B. Donati, D. Rotilio, (RE ARTU) Research Laboratories and Department of Oncology, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy)
Macromolecules as Paclitaxel Carriers: From Chemical Considerations to Clinical Applications;pp. 71-97
(Franco Dosio, Daniela Gastaldi, University of Torino, Italy)
Paclitaxel Crystals: Molecular Interactions, Nucleation and Growth, and Possible Implications on Cell Studies;pp. 99-132
(Javier S. Castro, Pierre A. Deymier, Bartosz Trzaskowski, Department of Materials Science and Engineering, University of Arizona, Tucson, Arizona, and others)
Second Primary Cancer in Children and Adults: A Comparison;pp. 133-151
(Carmen Mejia, Alberto Serrano-Olvera, Lena Ruiz-Azuara, Instituto de Investigaciones Biomédicas, UNAM, Instituto Nacional de Cancerología y Subdirección de Investigación Clínica del Departamento de Oncología Médica del Centro ABC, México)
Critical Evaluation of the Use of CD133 as a Cancer Stem Cell Marker in Solid Tumors;pp. 153-172
(Scott Bidlingmaier, Xiaodong Zhu, Yue Liu, Bin Liu, Department of Anesthesia, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California)
Psychosocial Oncology;pp. 173-188
(Kevin Bumpers, Emory University, Atlanta, Georgia)
Brain Metastases: Symptoms, Diagnosis and Treatment;pp. 189-203
(Semra Paydas, Cukurova University, Faculty of Medicine, Dept. of Oncology, Adana, Turkey)
Long-Term Recurrences and Second Tumors after Curative Surgery for Cancer of the Esophagus and Gastroesophageal Junction;pp. 205-222
(Andrés Sánchez-Pernaute, Norman Jael Cervantes, Óscar Cano Valderrama, María Elia Pérez-Aguirre, Antonio José Torres García, Department of Surgery, Hospital Clínico San Carlos, Complutense University of Madrid, Madrid, Spain)
Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer;pp. 223-236
(Hai-bo Sun, Si-yu Wang, Cancer Center of Sun Yat-sen University, Guangzhou, P.R. China)
Mitochondrial Dysfunction of AS-30D Rat Ascites Hepatoma Cells: Action of Zinc (II) and Sodium Selenite;pp. 237-253
(Elena A. Belyaeva, Laboratory of Comparative Biochemistry of Inorganic Ions, I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry RAS, St.-Petersburg, Russia)
Target Therapy for DSB Repair Deficient Tumors;pp. 255-267
(Akinori Egashira, Hiroshi Saeki, Eiji Oki, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara, Department of Surgery and Science, Graduate school of Medical Sciences, Kyushu University, Fukuoka, Japan)
Management of Recurrent Cervical Carcinoma;pp. 269-286
(C. Iavazzo, G.Vorgias, Department of Gynecology, Metaxa Memorial Hospital, Cancer Hospital,Piraeus, Greece)
Index
